Upneeq is the FIRST AND ONLY, FDA-approved, non-invasive treatment to improve low-lying lids by contracting the Mueller’s Muscle. Upneeq is used to treat acquired blepharoptosis in adults.

  • First In-Class Treatment
  • Active Ingredient Oxymetazoline Hydrochloride. 1%
  • Delivers rapid, visible lift to the upper eyelid with once-daily use
  • 1mm-3mm average lift of upper eyelid
  • Achieved significant visual field improvement
  • Some patients may start to observe efficiency 5-15 minutes post-dose, Lasting effect up to 8 hours post-dose
  • 0 Contraindications

See The Difference

UPQBA3 2hour
UPQBA1 1hour
UPQBA1 30min
UPQBA1 15min
UPQBA1 2hour
UPQBA2 2hour

Accessibility Toolbar

Scroll to Top